A detailed history of Rock Springs Capital Management LP transactions in Insmed Inc stock. As of the latest transaction made, Rock Springs Capital Management LP holds 683,344 shares of INSM stock, worth $45.3 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
683,344
Previous 808,356 15.46%
Holding current value
$45.3 Million
Previous $54.2 Million 7.89%
% of portfolio
1.7%
Previous 1.68%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$62.0 - $79.01 $7.75 Million - $9.88 Million
-125,012 Reduced 15.46%
683,344 $49.9 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $17.8 Million - $56.4 Million
808,356 New
808,356 $54.2 Million
Q1 2020

May 15, 2020

SELL
$13.63 - $33.98 $10.9 Million - $27.2 Million
-800,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $1.45 Million - $2.25 Million
-90,000 Reduced 10.11%
800,000 $19.1 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $920,000 - $1.29 Million
40,000 Added 4.71%
890,000 $22.8 Million
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $464,000 - $748,000
-40,000 Reduced 4.49%
850,000 $11.2 Million
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $1.23 Million - $1.83 Million
65,000 Added 7.88%
890,000 $18 Million
Q1 2018

May 15, 2018

BUY
$21.69 - $32.99 $4.59 Million - $6.98 Million
211,500 Added 34.47%
825,000 $18.6 Million
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $964,695 - $1.16 Million
-36,500 Reduced 5.62%
613,500 $19.1 Million
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $7.55 Million - $20.3 Million
650,000
650,000 $20.3 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.